TMO
Thermo Fisher Scientific Inc
678.40$
+2.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.0% | -5.0% | +1.9% | +0.5% | +7.5% | -9.0% | +4.7% | +2.5% | +9.8% | -9.9% | +9.0% | – | |
| – | +11.1% | -11.6% | +1.1% | +0.9% | +10.8% | -11.7% | +11.2% | -3.9% | +10.2% | -9.4% | +8.0% | – | |
| – | -8.7% | +6.7% | +3.0% | 0.0% | +2.9% | -5.0% | -4.6% | +13.2% | +9.3% | -10.7% | +10.4% | – | |
| – | +2.5% | +1.2% | +2.4% | +2.1% | +8.1% | -8.6% | +2.9% | -1.4% | +2.9% | -5.9% | +8.3% | – | |
| – | +35.1% | +2.4% | -3.3% | -0.6% | +5.0% | -5.7% | -14.4% | +21.5% | -8.6% | +10.3% | -12.5% | – | |
| – | -16.8% | +27.3% | +3.6% | -6.1% | -9.4% | +9.4% | -11.4% | +17.7% | +8.0% | -3.5% | +9.3% | – | |
| – | +0.9% | -13.6% | +2.2% | +9.0% | +18.4% | -18.9% | +4.2% | +8.2% | +10.9% | -19.1% | +12.0% | – | |
| – | +13.0% | -18.2% | +16.0% | +0.7% | -9.4% | -21.1% | +33.3% | -14.1% | +5.2% | -3.0% | +13.3% | – | |
| – | -0.5% | -7.3% | +4.3% | +2.8% | +14.2% | -18.6% | +6.5% | +6.8% | +16.1% | -18.3% | +11.0% | – | |
| – | +150.9% | +111.3% | -54.4% | -22.7% | +51.5% | -36.7% | -3.2% | +125.0% | -26.1% | -54.2% | +138.6% | – | |
| – | -5.0% | -18.5% | +16.6% | +5.3% | +12.3% | -17.7% | +7.3% | -0.1% | +22.2% | -16.4% | +5.1% | – | |
| – | +0.4% | -7.8% | +6.8% | -2.4% | +5.6% | -14.3% | +6.5% | +1.4% | +13.3% | -28.1% | +11.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.